Cargando…

In silico analysis of microRNA-510 as a potential oncomir in human breast cancer

Detalles Bibliográficos
Autores principales:	Gaj, Pawel, Zagozdzon, Radoslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053154/ https://www.ncbi.nlm.nih.gov/pubmed/25032262 http://dx.doi.org/10.1186/bcr3624

Ejemplares similares

Oncomirs: The potential role of non-coding microRNAs in understanding cancer
por: Manikandan, Jayapal, et al.
Publicado: (2008)

OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007)

Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer
por: Zhou, Yiran, et al.
Publicado: (2017)

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer
por: Guo, Qi J, et al.
Publicado: (2013)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Publicado: (2023)

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
por: Ward, Aoife, et al.
Publicado: (2014)

MicroRNA-510 mediated negative regulation of Caveolin-1 in fibroblasts promotes aggressive tumor growth
por: King, Brooke, et al.
Publicado: (2023)

In silico genetic robustness analysis of microRNA secondary structures: potential evidence of congruent evolution in microRNA
por: Shu, Wenjie, et al.
Publicado: (2007)

Toward Soluble 5,10-Diheterotruxenes: Synthesis and Reactivity of 5,10-Dioxatruxenes, 5,10-Dithiatruxenes, and 5,10-Diazatruxenes
por: Górski, Krzysztof, et al.
Publicado: (2020)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
por: de Almeida, Bruna Cristine, et al.
Publicado: (2017)

Master microRNA-222 regulates cardiac microRNA maturation and triggers Tetralogy of Fallot
por: Li, Chao, et al.
Publicado: (2022)

MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis
por: Liu, Haofeng, et al.
Publicado: (2022)

MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1
por: Wu, Wei, et al.
Publicado: (2019)

In Silico Analysis of MicroRNA Expression Data in Liver Cancer
por: Abu-Shahba, Nourhan, et al.
Publicado: (2023)

In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2022)

miR-21: an oncomir on strike in prostate cancer
por: Folini, Marco, et al.
Publicado: (2010)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
por: Bajor, Malgorzata, et al.
Publicado: (2018)

MicroRNA Precursors Are Not Structurally Robust but Plastic
por: Rodrigo, Guillermo, et al.
Publicado: (2013)

Human microRNA similarity in breast cancer
por: Jing, Ying, et al.
Publicado: (2021)

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma
por: Janiszewska, Joanna, et al.
Publicado: (2015)

Macros in microRNA target identification: A comparative analysis of in silico, in vitro, and in vivo approaches to microRNA target identification
por: Tarang, Shikha, et al.
Publicado: (2014)

Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors
por: MEHDIZADEHTAPEH, Leila, et al.
Publicado: (2021)

OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)

Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach
por: Manikandan, Mayakannan, et al.
Publicado: (2012)

Functional analysis of a novel, thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma
por: Kolanowska, Monika, et al.
Publicado: (2017)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

The 510(k) Third Party Review Program: Promise and Potential
por: Miller, Brian J., et al.
Publicado: (2023)

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
por: Monroig-Bosque, Paloma del C., et al.
Publicado: (2018)

The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
por: Xiang, Ying, et al.
Publicado: (2020)

In silico method for systematic analysis of feature importance in microRNA-mRNA interactions
por: Xiao, Jiamin, et al.
Publicado: (2009)

Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
por: Liu, Chia-Hsin, et al.
Publicado: (2022)

Systemic delivery of MicroRNA mimics with polyethylenimine elevates pulmonary microRNA levels, but lacks pulmonary selectivity
por: Schlosser, Kenny, et al.
Publicado: (2017)

In silico Analysis of Combinatorial microRNA Activity Reveals Target Genes and Pathways Associated with Breast Cancer Metastasis
por: Dombkowski, Alan A., et al.
Publicado: (2011)

Critical analysis of the potential for microRNA biomarkers in breast cancer management
por: Graveel, Carrie R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_06nmiaah5a6o8bqij9gbo032dd